IP Library Assignment 067410/0105
Patent Assignment
Reel/Frame 067410/0105

Security Interest

Recorded: 2024-05-14 Pages: 19
Assignors
TCR2 THERAPEUTICS INC.
Executed: 2024-05-14
ADAPTIMMUNE LIMITED
Executed: 2024-05-14
Assignee
HERCULES CAPITAL, INC., AS AGENT
400 HAMILTON AVENUE, SUITE 310, PALO ALTO, CALIFORNIA, 94301
Covered Properties (39)
Compositions and Methods for Tcr Reprogramming Using Fusion Proteins
Application: 18/600,309 →
Publication: US 2024/0301026
Compositions and Methods for Tcr Reprogramming Using Fusion Proteins
Application: 18/269,214 →
Publication: US 2024/0117002
Compositions and Methods for Tcr Reprogramming Using CD70 Specific Fusion Proteins
Application: 17/923,008 →
Publication: US 2024/0252641
T Cell Modification and Use Thereof
Application: 17/468,225 →
Publication: US 2022/0064305
T Cell Modification
Application: 17/297,380 →
Publication: US 2024/0050570
T Cell Receptors
Application: 17/361,524 →
Publication: US 2021/0324036
T Cell Receptors
Application: 18/339,663 →
Publication: US 2024/0218043
T Cell Receptors
Application: 18/363,672 →
Publication: US 2024/0010702
T Cell Receptors
Application: 17/574,152 →
Publication: US 2022/0127327
Lentiviral Transduction Methods
Application: 17/630,885 →
Publication: US 2022/0275395
Methods of Producing Haemogenic Progenitor Cells from Pluripotent Stem Cells
Application: 17/630,882 →
Publication: US 2022/0267733
Culture Medium for Haematopoietic Induction
Application: 17/630,880 →
Publication: US 2022/0275335
Methods of T Cell Production
Application: 17/630,884 →
Publication: US 2022/0267729
Method of Treatment of Cancer or Tumour
Application: 17/812,304 →
Publication: US 2022/0370559
Method of Treatment of Cancer or Tumour
Application: 17/819,480 →
Publication: US 2023/0390334
T Cell Manufacturing Process
Application: 18/046,874 →
Publication: US 2023/0133064
Method of Treatment of Cancer or Tumour
Application: 17/924,982 →
Publication: US 2023/0190803
Method of Treatment of Cancer or Tumour
Application: 17/924,980 →
Publication: US 2023/0190802
Modified Ipscs
Application: 17/924,926 →
Publication: US 2024/0016853
Methods of Producing Haemogenic Endothelial Cells from Pluripotent Stem Cells
Application: 18/546,821 →
Publication: US 2024/0124841
Methods of T Cell Production
Application: 18/291,856 →
Publication: US 2024/0327791
Modification of Cells with Heterologous T-Cell Receptor (Tcr) Coding Sequences
Application: 18/291,895 →
Publication: US 2024/0392244
T Cell Modification
Application: 17/272,865 →
Publication: US 2021/0317184
Compositions and Methods for Tcr Reprogramming Using Fusion Proteins
Application: 15/965,739 →
Publication: US 2018/0251514
Compositions and Methods for Tcr Reprogramming Using Fusion Proteins
Application: 15/965,738 →
Publication: US 2018/0244747
Compositions and Methods for Tcr Reprogramming Using Fusion Proteins
Application: 16/989,602 →
Publication: US 2020/0362011
Compositions and Methods for Tcr Reprogramming Using Fusion Proteins
Application: 18/069,749 →
Publication: US 2023/0235010
Vectors for Transgene Expression
Patent: 9,932,597 →
Application: 14/523,218 →
Publication: US 2015/0118714
T Cells with Increased Immunosuppression Resistance
Patent: 9,976,121 →
Application: 15/713,464 →
Publication: US 2018/0010095
T Cells With Increased Immunosuppression Resistance
Application: 15/949,018 →
Publication: US 2018/0298338
T Cell Modification and Use Thereof
Application: 15/998,475 →
Publication: US 2019/0100592
T Cell Receptors
Application: 15/006,224 →
Publication: US 2016/0137715
T Cell Receptors
Application: 16/416,907 →
Publication: US 2019/0330301
T Cell Receptors
Application: 17/501,122 →
Publication: US 2022/0031753
T Cell Receptors
Application: 17/820,529 →
Publication: US 2023/0028573
T Cell Receptors
Application: 17/501,200 →
Publication: US 2022/0025013
Compositions and Methods for Tcr Reprogramming Using Fusion Proteins
Application: 15/419,398 →
Publication: US 2017/0166622
Compositions and Methods for Tcr Reprogramming Using Fusion Proteins
Compositions and Methods for Tcr Reprogramming Using CD70 Specific Fusion Proteins
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 2, 2021
From: BRETT, SARA JANE; DAVIES, MARIE L.; SOUTHGATE, THOMAS
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 055462/0406 →
Assignment of Assignor's Interest Mar 2, 2021
From: ADAMS, KATHERINE; MELCHIORI, LUCA; RICE, LOUISE
To: ADAPTIMMUNE LTD.
Reel/Frame 055462/0505 →
Assignment of Assignor's Interest Nov 2, 2021
From: MELCHIORI, LUCA; BREWER, JOANNA
To: ADAPTIMMUNE LIMITED
Reel/Frame 057991/0455 →
Assignment of Assignor's Interest Aug 15, 2022
From: SILK, JONATHAN DAVID; LAM, EMILY PUO SAN; SEVKO, ALEXANDRA; WILLIAMS, DENNIS ROBERT
To: PALANTIR TECHNOLOGIES INC.
Reel/Frame 060811/0572 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded at Reel: 060811 Frame: 0572. Assignor(S) Hereby Confirms the Assignment. Oct 20, 2022
From: SILK, JONATHAN DAVID; LAM, EMILY PUO SAN; SEVKO, ALEXANDRA; WILLIAMS, DENNIS ROBERT
To: ADAPTIMMUNE LIMITED
Reel/Frame 062864/0755 →
Assignment of Assignor's Interest Oct 25, 2022
From: PUMPHREY, NICHOLAS JONATHAN
To: ADAPTIMMUNE LIMITED
Reel/Frame 061770/0720 →
Assignment of Assignor's Interest Nov 29, 2022
From: HOFMEISTER, ROBERT; WATT, AMY; GUTIERREZ, DARIO; COLLARD, ANDREW
To: TCR2 THERAPEUTICS INC.
Reel/Frame 062018/0765 →
Assignment of Assignor's Interest Jan 23, 2023
From: MARDILOVICH, KATERINA
To: ADAPTIMMUNE LIMITED
Reel/Frame 062447/0795 →
Assignment of Assignor's Interest Mar 28, 2023
From: YANG, CHENG TAO; CARPENTER, LEE
To: ADAPTIMMUNE LIMITED
Reel/Frame 063137/0404 →
Assignment of Assignor's Interest Mar 28, 2023
From: GUEGUEN, CLAIRE
To: ADAPTIMMUNE LIMITED
Reel/Frame 063137/0415 →
Assignment of Assignor's Interest Mar 28, 2023
From: SILK, JONATHAN; MCEWEN-SMITH, ROSANNA; JAPELJ, NIKA; HAMILTON, GARTH
To: ADAPTIMMUNE LIMITED
Reel/Frame 063137/0478 →
Assignment of Assignor's Interest Mar 28, 2023
From: YANG, CHENG TAO; CARPENTER, LEE
To: ADAPTIMMUNE LIMITED
Reel/Frame 063137/0885 →
Assignment of Assignor's Interest Apr 4, 2023
From: WILLIAMS, DENNIS ROBERT
To: ADAPTIMMUNE LIMITED
Reel/Frame 063223/0061 →
Assignment of Assignor's Interest Apr 4, 2023
From: DUDLEY, MARK EDWARD
To: ADAPTIMMUNE LIMITED
Reel/Frame 063222/0854 →
Assignment of Assignor's Interest May 26, 2023
From: HAMILTON, GARTH; SEIDL, CHRISTINE
To: ADAPTIMMUNE LIMITED
Reel/Frame 063773/0798 →
Assignment of Assignor's Interest Jun 22, 2023
From: TRIBBLE, NICHOLAS; LAWRANCE, WILLIAM; BAGG, ELEANOR
To: ADAPTIMMUNE LIMITED
Reel/Frame 064032/0332 →
Assignment of Assignor's Interest Jun 27, 2023
From: FLEURY, MICHELLE
To: TCR2 THERAPEUTICS INC.
Reel/Frame 064086/0386 →
Assignment of Assignor's Interest Jun 27, 2023
From: ARORA, POOJA
To: TCR2 THERAPEUTICS INC.
Reel/Frame 064144/0636 →
Assignment of Assignor's Interest Jun 27, 2023
From: TIGHE, ROBERT; HOFMEISTER, ROBERT; GUTIERREZ, DARIO; MCCARTHY, DERRICK
To: TCR2 THERAPEUTICS INC.
Reel/Frame 064086/0027 →
Assignment of Assignor's Interest Aug 1, 2023
From: TRIBBLE, NICHOLAS; LAWRANCE, WILLIAM; BAGG, ELEANOR
To: ADAPTIMMUNE LIMITED
Reel/Frame 064458/0786 →
Assignment of Assignor's Interest Aug 17, 2023
From: GARCIA-ALEGRIA, EVA
To: ADAPTIMMUNE LIMITED
Reel/Frame 064622/0404 →
Assignment of Assignor's Interest Jan 12, 2024
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
To: ADAPTIMMUNE LIMITED
Reel/Frame 066116/0456 →
Assignment of Assignor's Interest Apr 19, 2024
From: BAEUERLE, PATRICK; SIECZKIEWICZ, GREGORY; HOFMEISTER, ROBERT
To: TCR2 THERAPEUTICS INC.
Reel/Frame 067166/0475 →
Assignment of Assignor's Interest May 7, 2024
From: TRIBBLE, NICHOLAS; LAWRANCE, WILLIAM; BAGG, ELEANOR
To: ADAPTIMMUNE LIMITED
Reel/Frame 067335/0535 →
Assignment of Assignor's Interest Aug 6, 2024
From: HAMILTON, GARTH
To: ADAPTIMMUNE LIMITED
Reel/Frame 068201/0140 →